GSK wins US approval for twice-yearly asthma drug - Reuters

Reuters | Dec. 16, 2025, 8:27 p.m. | Original
GSK wins US approval for twice-yearly asthma drug Reuters
Australia government forced to lift inflation forecast, keeps spending plans intact - Reuters Apple in talks with Indian chipmakers to assemble, package iPhone components, ET reports - Reuters